Ginkgo Bioworks Holdings, Inc. DNA

Updated: 9 Aug 2026

NYSE | Biotech | Synthetic biology and cell programming

No signal published yet

We already track Ginkgo Bioworks Holdings and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Ginkgo Bioworks Holdings free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NYSE
Type
Biotech
Sector
Synthetic biology and cell programming
We're already tracking Ginkgo Bioworks Holdings, Inc. — here are the latest events we've registered

Recent News

  • On August 5, 2026, Ginkgo Bioworks reported its second quarter 2026 financial results, generating $20.2 million in revenue alongside a GAAP net loss of $57.3 million. Alongside the earnings update, the company announced contracts to construct autonomous laboratories for major universities including MIT, Caltech, Northwestern, and the University of Maryland. Ginkgo also reaffirmed its full-year 2026 cash burn guidance of $125 million to $150 million.

What Firelda Watch includes for Ginkgo Bioworks Holdings, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Ginkgo Bioworks Holdings, Inc. will be delivered in the same format.

Want to follow Ginkgo Bioworks Holdings, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Ginkgo Bioworks Holdings free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Ginkgo Bioworks Holdings, Inc. DNA
Ginkgo Bioworks Holdings — follow and we'll monitor it
Follow Ginkgo Bioworks Holdings free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.